Skip to content

Hamilton Lane

US · HLNE #2333 by market cap Listed 2017
81.07 -3.91 -4.60%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 32 in the most recent period (2026/Q3).
  • Total institutional ownership rose 6.7 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
118.39% +6.68pp
Institutions
488 +32
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund87.25%
Hedge Fund16.29%
Public Company7.56%
Individual/Insider4.98%
Private Company3.49%
Government Pension Fund1.41%
Sovereign Wealth Fund1.14%
Insurance Company0.96%
Family Office/Trust0.18%

Top holders as of 2026-09-30

BlackRock 9.88% · 4.30M sh
Kayne Anderson Rudnick Investment Management, LLC 7.02% · 3.05M sh
Vanguard Capital Management, LLC 4.08% · 1.78M sh
Vanguard Portfolio Management, LLC 4.04% · 1.76M sh
FMR 3.50% · 1.52M sh
Wasatch Advisors LP 3.34% · 1.45M sh
Juan Delgado-Moreira 3.16% · 1.38M sh
State Street Global Advisors 3.10% · 1.35M sh
Los Angeles Capital Management LLC 2.77% · 1.20M sh
Citadel Advisors LLC 2.77% · 1.20M sh
Geode Capital Management, LLC 2.45% · 1.05M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 35 buys · 15 sells

NameRoleStake
Juan Delgado-Moreira Co-Chief Executive Officer 3.16%
Hartley Rogers Co-CEO & Chairman of the Board 0.34%
Erik Hirsch Executive Co-Chairman & Member of the Board 0.24%
Mario Giannini Executive Co-Chairman 0.24%
Andrea Kramer Chief Operating Officer 0.20%
Margaret McAllister -- 0.14%
David Berkman Independent Director 0.11%
Thomas Kerr MD & Co-Head of Investments, Co-Head of Secondaries and Co-Head of Secondary Investments 0.11%
Lydia Gavalis General Counsel 0.08%
Michael Donohue Former Principal Accounting Officer, MD of Finance & Controller 0.07%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-15 Michael Schmertzler Independent Director Other Acquisition +977 --
2026-09-15 Andrea Kramer Chief Operating Officer Sale to Issuer -736 $93.03
2026-09-15 Andrea Kramer Chief Operating Officer Other Derivative Acquisition +22,252 --
2026-09-15 Leslie Varon Independent Director Other Acquisition +977 --
2026-09-15 Ormond Sexton Independent Director Other Acquisition +1,953 --
2026-09-15 Jeffrey Armbrister Chief Financial Officer Sale to Issuer -393 $93.03
2026-09-15 Jeffrey Armbrister Chief Financial Officer Other Derivative Acquisition +22,252 --
2026-09-15 Drew Carl MD & Chief Accounting Officer Other Derivative Acquisition +2,226 --
2026-09-09 Juan Delgado-Moreira Co-Chief Executive Officer Other Acquisition +50,000 --
2026-09-09 Juan Delgado-Moreira Co-Chief Executive Officer Other Disposition -50,000 --
2026-06-29 Andrea Kramer Chief Operating Officer Other Acquisition +27 $67.01
2026-06-29 Drew Carl MD & Chief Accounting Officer Other Acquisition +78 $67.01
2026-06-10 Andrea Kramer Chief Operating Officer Open Market Acquisition +1,283 $77.46
2026-06-10 Hartley Rogers Co-CEO & Chairman of the Board Open Market Acquisition +38,290 $77.86–78.73
2026-06-10 David Berkman Independent Director Open Market Acquisition +15,000 $76.27
2026-05-28 Andrea Kramer Chief Operating Officer Other Acquisition +3,605 $84.89
2026-05-28 Erik Hirsch Executive Co-Chairman & Member of the Board Other Acquisition +42,145 --
2026-05-28 Juan Delgado-Moreira Co-Chief Executive Officer Other Acquisition +38,087 --
2026-05-28 Jeffrey Armbrister Chief Financial Officer Other Acquisition +2,109 --
2026-05-28 Lydia Gavalis General Counsel Other Acquisition +1,139 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Hamilton Lane discussion 0 comments

Add a comment